• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Koo
  • Youtube
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

Tag: Bharat Biotech

Bharat Biotech
Covaxin Demonstrates Interim Clinical Efficacy Of 81%

Hyderabad: Bharat Biotech on Wednesday announced the first interim analysis of Covaxin, which shows the efficacy of the Covid-19 vaccine to be at 81 per cent. The Hyderabad-based vaccine maker said whole virion inactivated Covid-19 vaccine candidate demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved […]

vaccines
Covaxin, Covishield New Fact-Sheets: Know Who Can’t Take Vaccines, the Side-effects

Bhubaneswar: With the ‘vaccine hesitancy’ getting manifested in nearly half a dozen districts– including the Capital City– in the State despite a mere 0.01 per cent showing any AEFI (adverse events following immunisation) signs, the two vaccine manufacturers – Bharat Biotech and Serum Institute India – have released fact-sheets that tell who are eligible for […]

55L Covaxin Procured For Rs 206 Per Dose, 1.1 Cr Covidshield Vaccines For Rs 200 A Piece
55L Covaxin Procured For Rs 206 Per Dose, 1.1 Cr Covidshield Vaccines For Rs 200 A Piece

New Delhi: Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of Rs 200 and Rs 206 per dose, respectively. However, BBIL will provide 16.5 lakh doses of Covaxin free of cost […]

Serum Institute, Bharat Biotech Pledge For Smooth Rollout Of COVID-19 Vaccines
Serum Institute, Bharat Biotech Pledge For Smooth Rollout Of COVID-19 Vaccines

New Delhi: Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of COVID-19 vaccines in the country and the world. In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, […]

COVID-19 Vaccine: Bharat Biotech Dispatches 1st Batch Of Covaxin For Immunisation Drive
COVID-19 Vaccine: Bharat Biotech Dispatches 1st Batch Of Covaxin For Immunisation Drive

New Delhi: Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccine, Covaxin, to the government for further distribution as the immunisation drive in the country is set to start in coming days, its CMD Dr Krishna Ella said on Monday. “We have already sent the batch to the Central Research Institute in […]

COVAXIN
AIDAN Asks DCGI To Withdraw Approval For Bharat Biotech's Covid-19 Vaccine

New Delhi: The All India Drug Action Network (AIDAN) said it is shocked to learn of the SEC’s recommendation to grant REU approval to Bharat Biotech’s COVAXIN in “clinical trial mode” and “specially in the context of infection by mutant strains”. “In light of the intense concerns arising from the absence of efficacy data and […]

Expert Panel Recommends Bharat Biotech's 'Covaxin' For Emergency Use
Expert Panel Recommends Bharat Biotech's 'Covaxin' For Emergency Use

New Delhi: The Subject Expert Committee of Central Drug Standard Control Organization on Saturday recommended Bharat Biotech’s ‘Covaxin’ for emergency use in India. However, the final decision on its approval will be taken by the Drug Controller General of India (DCGI). Expert panel recommends granting permission for restricted emergency use authorization for Bharat Biotech’s indigenously […]

Bharat Biotech Calls Out For Participating In Covaxin Phase 3 Trials To Ensure Protection Against Covid-19
Bharat Biotech Calls Out For Participating In Covaxin Phase 3 Trials To Ensure Protection Against Covid-19

New Delhi: Bharat Biotech has said that it will be advisable to participate in the Phase 3 efficacy trial for its indigenous Covaxin and get vaccinated to ensure protection against Covid-19 as it may take months for people above 50 years to get the vaccine. In frequently asked questions (FAQ) on its vaccine trials, Bharat […]

Covaxin
Bharat Biotech Recruits 13K Volunteers For Covaxin Phase III Trials

Hyderabad: Bharat Biotech on Tuesday announced successful recruitment of 13,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for Phase III clinical trial of its coronavirus vaccine Covaxin across multiple sites in India. The Phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India. […]

COVAXIN
Inactivated Vaccines Are Safest With Lesser Adverse Reactions: Bharat Biotech

New Delhi: Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine, DNA-based vaccine, vector-based vaccine, or live attenuated vaccines, etc., the inactivated vaccines being developed by it for Covid 19 are safest, and hence, the adverse reactions are lesser. In a series of frequently asked questions (FAQs) for its […]

Envoys Of 64 Countries Visit COVID-19 Vaccine Makers In Hyderabad
Envoys Of 64 Countries Visit COVID-19 Vaccine Makers In Hyderabad

Hyderabad: Envoys of 64 countries on Wednesday visited the facilities of Bharat Biotech and Biological E, which are developing vaccines for coronavirus. After landing in Hyderabad by a special Air India flight, the Ambassadors and High Commissioners from the countries in Asia, Africa, Europe, North America, South America, and Oceania reached Genome Valley on the […]

COVID Vaccine: Bharat Biotech Seeks Emergency Use Nod For Covaxin
COVID Vaccine: Bharat Biotech Seeks Emergency Use Nod For Covaxin

New Delhi: Hyderabad-based Bharat Biotech on Monday filed an application with the Drugs Controller General of India (DCGI) for emergency use authorisation of its Covid-19 vaccine- Covaxin. The application was filed before the apex drug regulator on Monday evening, a company source told IANS on the condition of anonymity. Covaxin, India’s indigenous Covid-19 vaccine by […]

COVID-19 Vaccines
Singapore To Contribute $5Mn To Help Other Countries Get COVID-19 Vaccines

Singapore: Singapore announced to contribute $5 million on Friday to support low- and lower-middle-income countries procure Covid-19 vaccines. The announcement was made in a joint statement by the Ministries of Foreign Affairs and Health, reports Xinhua news agency. The money would go through the Covid-19 Vaccine Global Access (COVAX) Advance Market Commitment (AMC) mechanism, which […]

Indian Health Experts Hail mRNA Vaccine For Covid Treatment
Covid-19 Vaccination In Odisha: Chief Minister Announces Priority Groups

Bhubaneswar: Chief Minister Naveen Patnaik on Wednesday announced that people above 60 years, pregnant women and health workers will be given priority during the vaccination process for Covid-19 once the vaccine is available. He made the announcement while reviewing the Coronavirus scenario in the State. The Odisha government had already commenced process for the preparation […]

Covaxin's Phase-3 Trials Begin: Bharat Biotech
Covaxin's Phase-3 Trials Begin: Bharat Biotech

Hyderabad: Phase-3 trials of Covaxin, India’s first indigenous vaccine for Covid-19 commenced today, vaccine maker Bharat Biotech announced on Monday. The Phase-3 trials, which involve 26,000 volunteers across India, are being conducted in partnership with the Indian Council of Medical Research (ICMR). This is India’s first Phase-3 efficacy study for a Covid-19 vaccine, and the […]

Bharat Biotech: Vaccinating 130Cr People With Covaxin A Challenge
Bharat Biotech: Vaccinating 130Cr People With Covaxin A Challenge

Hyderabad: Bharat Biotech on Monday raised the logistical query on “how to vaccinate 1.3 billion (130 crore) people with two injectable doses of India’s first indigenous coronavirus vaccine Covaxin”. Terming the exercise a “challenge” it also said that work was on single-dose nasal drop vaccine. Bharat Biotech’s comment comes while Covaxin is entering its third […]

COVAXIN
COVID-19 Vaccine Likely By February 2021!

Bhubaneswar: With scientists across the world working overtime to prepare a vaccine for Covid-19 by the year end, it is expected that the vaccine could be introduced in India as early as February,2021. Speculations became rife after Bharat Biotech’s Covid-19 vaccine candidate showed safety and efficacy during the phase 1 and 2 trials as well […]

Bharat Biotech: No Major Adverse Events In 2 Phases Of Covaxin Trials
Bharat Biotech: No Major Adverse Events In 2 Phases Of Covaxin Trials

Hyderabad: Bharat Biotech, which recently received approval to conduct Phase III human trials of India’s first indigenous coronavirus vaccine, Covaxin, has said that the vaccine has been found to be safe without any major adverse events in the first two stages of trials and that its goal is to attain strong immune response rate in […]

covaxin
Covid Vaccine Alert: Phase III Trials Of Covaxin In Odisha Soon

Bhubaneswar: The third and final phase of the ongoing clinical trials of Covaxin – India’s indigenous Covid-19 vaccine candidate will shortly begin in Odisha. The Phase III trials of Covaxin will be conducted at 21 centres across India and at SUM hospital in Odisha (Bhubaneswar). The vaccine will be administered to nearly 2,000 volunteers in […]

Bharat Biotech, Washington Varsity Developing Intranasal Vaccine For Covid: Union Health Min
Bharat Biotech, Washington Varsity Developing Intranasal Vaccine For Covid: Union Health Min

New Delhi: Union Health Minister Harsh Vardhan on Sunday informed that Bharat Biotech will develop an intranasal vaccine for Sars-CoV-2, the virus that causes Covid-19. The minister said that the Hyderabad-based drugs and vaccine research and manufacturing company has entered into an agreement with Washington University and St. Louis University for the trials of the […]

bharat-biotech
COVID-19 Vaccine: Bharat Biotech Inks Deal With Washington Varsity For Intranasal Vax

Hyderabad: Leading vaccine maker Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for Covid-19. The Hyderabad-based company owns the rights to distribute the vaccine in all markets except USA, Japan and Europe. While the Phase I trials will […]

Covaxin's Phase-3 Trials Begin: Bharat Biotech
COVID-19 Vaccine: Animal Study Proved Vax's Efficacy, Says Bharat Biotech

Hyderabad: Vaccine maker Bharat Biotech on Friday announced that the animal trials of its Covid-19 vaccine candidate Covaxin were successful. It said the results demonstrated the protective efficacy of the vaccine in a live viral challenge model. “Bharat Biotech proudly announces the animal study results of COVAXIN – These results demonstrate the protective efficacy in […]

COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax
COVID-19 Vaccine: Stage Set For Phase II Clinical Trials Of Bharat Biotech's Vax

Hyderabad: The stage is set for phase II clinical trials of Bharat Biotech’s coronavirus vaccine from Monday. The Hyderabad-based vaccine maker received the approval from Central Drugs Standard Control Organisation under the Directorate General of Health Services to conduct the phase II trials of indigenous vaccine candidate Covaxin. Joint Drugs Controller Dr S. Eswara Reddy […]

COVID19 Vaccine in India
Seven Indian Pharma Players Race To Develop COVID-19 Vaccine

New Delhi: At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally. Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological […]

Covaxin
COVID Vaccine: Bharat Biotech Begins Human Trial Of Covaxin In India

Chandigarh: The human trial of Bharat Biotech’s anti-COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted. In his tweet, the minister also said the vaccine has been administered to three persons who have shown no adverse effect to it. “Human trial with Corona vaccine (COVAXIN) […]

scrollToTop